Xiamen Innovax Biotech confirmed it has launched Hecolin, the world's first hepatitis E vaccine, in the China market. The SFDA approved the vaccine in January of this year. According to Innovax, the government is cooperating in an effort to offer the vaccine to high-risk individuals in China. More details.... Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});